These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 17579517)

  • 1. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1.
    Pridgeon JW; Olzmann JA; Chin LS; Li L
    PLoS Biol; 2007 Jul; 5(7):e172. PubMed ID: 17579517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAP1 rescues PINK1 loss-of-function phenotypes.
    Zhang L; Karsten P; Hamm S; Pogson JH; Müller-Rischart AK; Exner N; Haass C; Whitworth AJ; Winklhofer KF; Schulz JB; Voigt A
    Hum Mol Genet; 2013 Jul; 22(14):2829-41. PubMed ID: 23525905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of oxidative stress-induced heme oxygenase-1 expression by the defect of Parkinson-related gene of PINK1.
    Chien WL; Lee TR; Hung SY; Kang KH; Lee MJ; Fu WM
    J Neurochem; 2011 May; 117(4):643-53. PubMed ID: 21366594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1.
    Weihofen A; Ostaszewski B; Minami Y; Selkoe DJ
    Hum Mol Genet; 2008 Feb; 17(4):602-16. PubMed ID: 18003639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drosophila Trap1 protects against mitochondrial dysfunction in a PINK1/parkin model of Parkinson's disease.
    Costa AC; Loh SH; Martins LM
    Cell Death Dis; 2013 Jan; 4(1):e467. PubMed ID: 23328674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Necrosis Factor Receptor-associated Protein 1 (TRAP1) Mutation and TRAP1 Inhibitor Gamitrinib-triphenylphosphonium (G-TPP) Induce a Forkhead Box O (FOXO)-dependent Cell Protective Signal from Mitochondria.
    Kim H; Yang J; Kim MJ; Choi S; Chung JR; Kim JM; Yoo YH; Chung J; Koh H
    J Biol Chem; 2016 Jan; 291(4):1841-1853. PubMed ID: 26631731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c.
    Wang HL; Chou AH; Yeh TH; Li AH; Chen YL; Kuo YL; Tsai SR; Yu ST
    Neurobiol Dis; 2007 Nov; 28(2):216-26. PubMed ID: 17707122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.
    Butler EK; Voigt A; Lutz AK; Toegel JP; Gerhardt E; Karsten P; Falkenburger B; Reinartz A; Winklhofer KF; Schulz JB
    PLoS Genet; 2012 Feb; 8(2):e1002488. PubMed ID: 22319455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1.
    Sim CH; Lio DS; Mok SS; Masters CL; Hill AF; Culvenor JG; Cheng HC
    Hum Mol Genet; 2006 Nov; 15(21):3251-62. PubMed ID: 17000703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced vulnerability of PARK6 patient skin fibroblasts to apoptosis induced by proteasomal stress.
    Klinkenberg M; Thurow N; Gispert S; Ricciardi F; Eich F; Prehn JH; Auburger G; Kögel D
    Neuroscience; 2010 Mar; 166(2):422-34. PubMed ID: 20045449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial cell death control in familial Parkinson disease.
    Kroemer G; Blomgren K
    PLoS Biol; 2007 Jul; 5(7):e206. PubMed ID: 17638420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial chaperone Trap1 and the calcium binding protein Sorcin interact and protect cells against apoptosis induced by antiblastic agents.
    Landriscina M; Laudiero G; Maddalena F; Amoroso MR; Piscazzi A; Cozzolino F; Monti M; Garbi C; Fersini A; Pucci P; Esposito F
    Cancer Res; 2010 Aug; 70(16):6577-86. PubMed ID: 20647321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease.
    Fitzgerald JC; Zimprich A; Carvajal Berrio DA; Schindler KM; Maurer B; Schulte C; Bus C; Hauser AK; Kübler M; Lewin R; Bobbili DR; Schwarz LM; Vartholomaiou E; Brockmann K; Wüst R; Madlung J; Nordheim A; Riess O; Martins LM; Glaab E; May P; Schenke-Layland K; Picard D; Sharma M; Gasser T; Krüger R
    Brain; 2017 Sep; 140(9):2444-2459. PubMed ID: 29050400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential submitochondrial localization of PINK1 as a molecular switch for mediating distinct mitochondrial signaling pathways.
    Fallaize D; Chin LS; Li L
    Cell Signal; 2015 Dec; 27(12):2543-54. PubMed ID: 26436374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner.
    Moriwaki Y; Kim YJ; Ido Y; Misawa H; Kawashima K; Endo S; Takahashi R
    Neurosci Res; 2008 May; 61(1):43-8. PubMed ID: 18359116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma.
    Condelli V; Maddalena F; Sisinni L; Lettini G; Matassa DS; Piscazzi A; Palladino G; Amoroso MR; Esposito F; Landriscina M
    Oncotarget; 2015 Sep; 6(26):22298-309. PubMed ID: 26084290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1.
    Sanchez-Martin C; Menon D; Moroni E; Ferraro M; Masgras I; Elsey J; Arbiser JL; Colombo G; Rasola A
    Antioxid Redox Signal; 2021 Mar; 34(7):505-516. PubMed ID: 32438819
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of the regulatory and catalytic domains of PTEN-induced kinase-1 (PINK1).
    Sim CH; Gabriel K; Mills RD; Culvenor JG; Cheng HC
    Hum Mutat; 2012 Oct; 33(10):1408-22. PubMed ID: 22644621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of Neurofibromin Induces an Oncogenic Metabolic Switch via Mitochondrial ERK-Mediated Phosphorylation of the Chaperone TRAP1.
    Masgras I; Ciscato F; Brunati AM; Tibaldi E; Indraccolo S; Curtarello M; Chiara F; Cannino G; Papaleo E; Lambrughi M; Guzzo G; Gambalunga A; Pizzi M; Guzzardo V; Rugge M; Vuljan SE; Calabrese F; Bernardi P; Rasola A
    Cell Rep; 2017 Jan; 18(3):659-672. PubMed ID: 28099845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of tumor necrosis factor receptor-associated protein 1 expression induces inhibition of cell proliferation and tumor growth in human esophageal cancer cells.
    Tian X; Ma P; Sui CG; Meng FD; Li Y; Fu LY; Jiang T; Wang Y; Jiang YH
    FEBS J; 2014 Jun; 281(12):2805-19. PubMed ID: 24754231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.